Kevin D. Freeman - 18 Apr 2022 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
18 Apr 2022
Net transactions value
+$8,550
Form type
4
Filing time
18 Apr 2022, 15:59:53 UTC
Previous filing
25 Jan 2022
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $8,550 +5,000 +9.1% $1.71 60,000 18 Apr 2022 By a limited liability company controlled by the Reporting Person: Freeman Global Holdings LLC F1
holding GALT Common Stock 23,469 18 Apr 2022 Direct
holding GALT Common Stock 16,000 18 Apr 2022 IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.